BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26123439)

  • 1. Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.
    Mauger F; Dulary C; Daviaud C; Deleuze JF; Tost J
    Anal Bioanal Chem; 2015 Sep; 407(22):6873-8. PubMed ID: 26123439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of commercial kits for purification of circulating free DNA.
    Diefenbach RJ; Lee JH; Kefford RF; Rizos H
    Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis.
    Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S
    Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.
    Li M; Jia Y; Xu J; Cheng X; Xu C
    Ann Hematol; 2017 Aug; 96(8):1343-1351. PubMed ID: 28623396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.
    Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows.
    Lehle S; Emons J; Hack CC; Heindl F; Hein A; Preuß C; Seitz K; Zahn AL; Beckmann MW; Fasching PA; Ruebner M; Huebner H
    Sci Rep; 2023 Jan; 13(1):373. PubMed ID: 36611077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
    Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E
    Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
    Kawahara A; Fukumitsu C; Taira T; Abe H; Takase Y; Murata K; Yamaguchi T; Azuma K; Ishii H; Takamori S; Akiba J; Hoshino T; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):620-8. PubMed ID: 26235264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
    J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony® SP Instrument.
    Wolf A; Beller K; Groemminger S; Hofmann W; Sachse M; Fassunke J
    Adv Exp Med Biol; 2016; 924():179-185. PubMed ID: 27753041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.
    Pinzani P; Salvianti F; Cascella R; Massi D; De Giorgi V; Pazzagli M; Orlando C
    Clin Chim Acta; 2010 Sep; 411(17-18):1319-24. PubMed ID: 20576522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Plasma Tumor DNA.
    Parsons HA; Beaver JA; Park BH
    Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
    Board RE; Williams VS; Knight L; Shaw J; Greystoke A; Ranson M; Dive C; Blackhall FH; Hughes A
    Ann N Y Acad Sci; 2008 Aug; 1137():98-107. PubMed ID: 18837931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.
    Mouliere F; El Messaoudi S; Pang D; Dritschilo A; Thierry AR
    Mol Oncol; 2014 Jul; 8(5):927-41. PubMed ID: 24698732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.
    Devonshire AS; Whale AS; Gutteridge A; Jones G; Cowen S; Foy CA; Huggett JF
    Anal Bioanal Chem; 2014 Oct; 406(26):6499-512. PubMed ID: 24853859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Technology for Enrichment of Biomolecules from Cell-Free Body Fluids and Subsequent DNA Sizing.
    Patel V; Celec P; Grunt M; Schwarzenbach H; Jenneckens I; Hillebrand T
    Adv Exp Med Biol; 2016; 924():165-169. PubMed ID: 27753038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for isolation of cell-free plasma DNA strongly affect DNA yield.
    Fleischhacker M; Schmidt B; Weickmann S; Fersching DM; Leszinski GS; Siegele B; Stötzer OJ; Nagel D; Holdenrieder S
    Clin Chim Acta; 2011 Nov; 412(23-24):2085-8. PubMed ID: 21861994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
    Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
    Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
    Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.